US equities
|
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
AbCellera Biologics Inc. - Common Shares
(NQ:
ABCL
)
9.690
-0.780 (-7.45%)
Delayed Quote
Updated: 4:00 PM EST, Nov 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbCellera Biologics Inc. - Common Shares
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
New AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical Trials
May 04, 2021
From
AbCellera Biologics Inc.
Via
Business Wire
22 Stocks Moving in Monday's Pre-Market Session
↗
May 03, 2021
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) rose 58.3% to $78.90 in pre-market trading. Nicholas Jason Singer disclosed a 9.13% passive stake in Brooklyn...
Via
Benzinga
AbCellera Breaks Ground on Global Headquarters in Vancouver and Expects to Hire Hundreds of Scientific and Tech Professionals
April 29, 2021
From
AbCellera
Via
Business Wire
Tuesday Market Report
↗
April 27, 2021
Swiss ABB gained 0.8% more today after it reported on its Q1 today, confirming the pre-announced data from earlier in April.
Via
Talk Markets
London Cancel
↗
April 26, 2021
Brazilian Cosan is up 0.43% despite desperate Covid-19 outbreaks along the Amazon.
Via
Talk Markets
Earth Day
↗
April 22, 2021
Once again the exchanges are unsure if they want to go up or down.
Via
Talk Markets
AbCellera to Report First Quarter 2021 Financial Results on May 13, 2021
April 21, 2021
From
AbCellera
Via
Business Wire
The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split
↗
April 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
AbCellera and Empirico Announce Strategic Multi-Target Antibody Discovery Collaboration
April 14, 2021
From
AbCellera Biologics Inc.
Via
Business Wire
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >